ZENOTECHPharmaceuticals
Zenotech Laboratories Ltd — Profit & Loss Statement
₹34.29
-5.60%
Zenotech Laboratories Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.58 Cr | 0.00 | 0.01 Cr | 0.02 Cr | — |
| Tax Rate For Calcs | 0.30 | 0.26 | 0.20 | 0.30 | — |
| Normalized EBITDA | 15.73 Cr | 18.23 Cr | 21.73 Cr | 18.01 Cr | — |
| Total Unusual Items | 1.92 Cr | 0.00 | 0.06 Cr | 0.08 Cr | — |
| Total Unusual Items Excluding Goodwill | 1.92 Cr | 0.00 | 0.06 Cr | 0.08 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 5.61 Cr | 8.30 Cr | 11.59 Cr | 22.18 Cr | — |
| Reconciled Depreciation | 6.96 Cr | 7.09 Cr | 7.17 Cr | 6.97 Cr | — |
| Reconciled Cost Of Revenue | 0.84 Cr | 0.00 | 3.57 Cr | 2.55 Cr | — |
| EBITDA | 17.65 Cr | 18.23 Cr | 21.79 Cr | 18.09 Cr | — |
| EBIT | 10.69 Cr | 11.14 Cr | 14.61 Cr | 11.12 Cr | — |
| Net Interest Income | 0.00 | 0.00 | 0.26 Cr | -1.12 Cr | — |
| Interest Expense | 0.00 | 0.00 | 0.11 Cr | 1.22 Cr | — |
| Normalized Income | 4.27 Cr | 8.30 Cr | 11.54 Cr | 22.12 Cr | — |
| Net Income From Continuing And Discontinued Operation | 5.61 Cr | 8.30 Cr | 11.59 Cr | 22.18 Cr | — |
| Total Expenses | 31.76 Cr | 26.62 Cr | 28.89 Cr | 26.08 Cr | — |
| Diluted Average Shares | 6.10 Cr | 6.10 Cr | 6.10 Cr | 6.10 Cr | — |
| Basic Average Shares | 6.10 Cr | 6.10 Cr | 6.10 Cr | 6.10 Cr | — |
| Diluted EPS | 0.92 | 1.36 | 1.90 | 3.63 | — |
| Basic EPS | 0.92 | 1.36 | 1.90 | 3.63 | — |
| Diluted NI Availto Com Stockholders | 5.61 Cr | 8.30 Cr | 11.59 Cr | 22.18 Cr | — |
| Net Income Common Stockholders | 5.61 Cr | 8.30 Cr | 11.59 Cr | 22.18 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 5.61 Cr | 8.30 Cr | 11.59 Cr | 22.18 Cr | — |
| Net Income Including Noncontrolling Interests | 5.61 Cr | 8.30 Cr | 11.59 Cr | 22.18 Cr | — |
| Net Income Continuous Operations | 5.61 Cr | 8.30 Cr | 11.59 Cr | 22.18 Cr | — |
| Tax Provision | 5.08 Cr | 2.84 Cr | 2.92 Cr | -12.27 Cr | — |
| Pretax Income | 10.69 Cr | 11.14 Cr | 14.50 Cr | 9.90 Cr | — |
| Other Non Operating Income Expenses | 1.55 Cr | 1.00 Cr | 4.73 Cr | 4.52 Cr | — |
| Special Income Charges | 1.92 Cr | 0.00 | 0.06 Cr | 0.08 Cr | — |
| Net Non Operating Interest Income Expense | 0.00 | 0.00 | 0.26 Cr | -1.12 Cr | — |
| Interest Expense Non Operating | 0.00 | 0.00 | 0.11 Cr | 1.22 Cr | — |
| Operating Income | 7.22 Cr | 10.14 Cr | 9.46 Cr | 6.42 Cr | — |
| Operating Expense | 30.92 Cr | 26.62 Cr | 25.32 Cr | 23.52 Cr | — |
| Other Operating Expenses | 15.65 Cr | 14.15 Cr | 8.03 Cr | 7.55 Cr | — |
| Depreciation And Amortization In Income Statement | 6.96 Cr | 7.09 Cr | 7.17 Cr | 6.97 Cr | — |
| Depreciation Income Statement | 6.96 Cr | 7.09 Cr | 7.17 Cr | 6.97 Cr | — |
| Gross Profit | 38.14 Cr | 36.76 Cr | 34.78 Cr | 29.94 Cr | — |
| Cost Of Revenue | 0.84 Cr | 0.00 | 3.57 Cr | 2.55 Cr | — |
| Total Revenue | 38.98 Cr | 36.76 Cr | 38.35 Cr | 32.49 Cr | — |
| Operating Revenue | 38.98 Cr | 36.76 Cr | 38.35 Cr | 32.49 Cr | — |
| Interest Income | — | 0.95 Cr | 0.37 Cr | 0.10 Cr | 0.05 Cr |
| Other Special Charges | — | 0.03 Cr | -0.06 Cr | -0.08 Cr | -0.29 Cr |
| Write Off | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Income Non Operating | — | 0.95 Cr | 0.37 Cr | 0.10 Cr | 0.05 Cr |
| Selling General And Administration | — | 1.19 Cr | 0.99 Cr | 0.92 Cr | 0.69 Cr |
| Selling And Marketing Expense | — | 0.02 Cr | 0.02 Cr | 0.02 Cr | 0.02 Cr |
| General And Administrative Expense | — | 1.17 Cr | 0.97 Cr | 0.89 Cr | 0.67 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Zenotech Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.